ReBio is a Biomedical company with a mission to create impactful improvements to high value medical products through the optimisation of drug release profiles. We target indication areas where existing products are not optimal and can be improved upon with better clinical outcomes.

Our technology platform includes proprietary processes that improve the production of polymers which are tailorable to meet the needs of the indication.

We have one of the most experienced team of polymer formulators in the world and they are situated in our R&D centres in Finland  and the UK, where we also have a dedicated medical grade biopolymer manufacturing facility.

Our polymer gel-based technology platform SISU® enables us to tailor and enhance the release profile and duration of long-acting injectable small molecule and biomolecule drugs from a week to months.